SCHEMBL30945667

SCHEMBL30945667

Cc1ccc2c(c1)C1CN(C)CCC1N2C(=O)c1cc(F)ccc1Br

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.64
▸ KDM4E B2RXH2 1/20 0.62
▸ MAPT P10636 5/20 0.61
▸ MAPK1 P28482 1/20 0.60
▸ HTT P42858 2/20 0.58
▸ F2 P00734 1/20 0.58
▸ MEN1 O00255 4/20 0.55
▸ KMT2A Q03164 4/20 0.55
▸ LMNA P02545 3/20 0.54
▸ TSHR P16473 1/20 0.54
▸ CYP1A2 P05177 2/20 0.53
▸ CYP2D6 P10635 2/20 0.53
▸ CYP2C9 P11712 2/20 0.53
▸ CYP2C19 P33261 2/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ MCL1 Q07820 1/20 0.52
▸ POLB P06746 2/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12868685 0.85 ALDH1A1 (0.65) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL30945674 0.79 ALDH1A1 (0.63) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL29223991 0.79 ALDH1A1 (0.67) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL12868610 0.78 ALDH1A1 (0.70) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL12882736 0.78 MAPT (0.81) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL12868618 0.77 ALDH1A1 (0.65) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL30945708 0.77 SMN1; SMN2 (0.73) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL12868596 0.76 MAPT (0.66) ALDH1A1KDM4EMAPTMAPK1MEN1
SCHEMBL12868647 0.76 MAPT (0.66) ALDH1A1KDM4EMAPTMAPK1HTT
SCHEMBL30945702 0.75 ALDH1A1 (0.62) ALDH1A1KDM4EMAPTMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS CULLGEN (SHANGHAI), INC. (CN) 2024-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS DCAF1, DDB1, CUL4A ALDH1A1 2985/4885KDM4E 1056/4885MAPT 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback